arrow_back Back to App

Sickle Cell Disease Awareness Month: Increased Support and Treatment Access

This resolution supports designating September 2024 as Sickle Cell Disease Awareness Month. Its goal is to increase public knowledge about the disease, the need for research, early detection, and better treatment methods, which can improve the quality of life for affected individuals and their families.
Key points
Increasing public awareness of sickle cell disease, its symptoms, and complications.
Supporting research into new, more effective treatments and early detection methods for the disease.
Striving to ensure equitable access to innovative therapies for all patients, regardless of their background or economic status.
Calling on the government to remove barriers to specialized treatment access within the Medicaid and Medicare systems.
Encouraging the organization of educational events to raise awareness about the disease and available care programs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_1495
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Process start date: 2024-09-24
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 2024 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_1495.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-09-24.

What are the main provisions?

Key points include:

  • Increasing public awareness of sickle cell disease, its symptoms, and complications.
  • Supporting research into new, more effective treatments and early detection methods for the disease.
  • Striving to ensure equitable access to innovative therapies for all patients, regardless of their background or economic status.
  • Calling on the government to remove barriers to specialized treatment access within the Medicaid and Medicare systems.
  • Encouraging the organization of educational events to raise awareness about the disease and available care programs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Danny K. [D-IL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health